Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus-transformed human lymphoblastoid B-cell lines
- PMID: 3019572
- DOI: 10.1016/0008-8749(86)90228-5
Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus-transformed human lymphoblastoid B-cell lines
Abstract
Cells other than the macrophage can function as antigen-presenting cells (APCs). These class II-bearing accessory cells include dendritic cells, epidermal Langerhans cells, B cells, murine B-cell tumors, and human Epstein-Barr virus-transformed lymphoblastoid cell lines (EBV-LCL). We investigated the ability of EBV-LCL to present two soluble antigens, Candida albicans and purified protein derivative of tuberculin (PPD). The EBV-LCL derived from B cells of two different individuals can present both antigens to bulk cultures of autologous antigen-primed peripheral blood lymphocytes. The responses of PPD-reactive T-cell clones were weaker to PPD when presented by EBV-LCL than by PBL-APCs, with some clones responding only to PPD presented by PBL-APCs. This suggests that EBV-LCL are not equivalent to PBL monocytes in APC function, and that expression of class II major histocompatibility complex antigen is not sufficient in enabling antigen-presenting capability.
Similar articles
-
Differential antigen presentation by heat-treated peripheral blood mononuclear cells and Epstein-Barr virus-transformed lymphoblastoid cell lines (EBV-LCL): heated EBV-LCL present alloantigen and soluble antigen but are deficient in the stimulation of autologous EBV-LCL primed T cells.Hum Immunol. 1987 Jul;19(3):163-77. doi: 10.1016/0198-8859(87)90067-x. Hum Immunol. 1987. PMID: 3040644
-
Presentation of soluble antigen to human T cells by products of multiple HLA-linked loci: analysis of antigen presentation by a panel of cloned, autologous, HLA-mutant Epstein-Barr virus-transformed lymphoblastoid cell lines.Hum Immunol. 1987 Jan;18(1):75-91. doi: 10.1016/0198-8859(87)90114-5. Hum Immunol. 1987. PMID: 3542914
-
Efficient class II major histocompatibility complex presentation of endogenously synthesized hepatitis C virus core protein by Epstein-Barr virus-transformed B-lymphoblastoid cell lines to CD4(+) T cells.J Virol. 1998 Oct;72(10):8301-8. doi: 10.1128/JVI.72.10.8301-8308.1998. J Virol. 1998. PMID: 9733874 Free PMC article.
-
Use of Epstein-Barr virus-transformed, autologous B-lymphoblastoid cells as antigen-presenting cells for establishment and maintenance of dengue virus-specific, human cytotoxic T lymphocyte clones.J Virol Methods. 1997 Aug;67(1):77-84. doi: 10.1016/s0166-0934(97)00082-7. J Virol Methods. 1997. PMID: 9274820
-
Migration inhibition factor secreting human T-cell lines reactive to PPD: a study of their antigen specificity, MHC restriction and the use of Epstein-Barr virus-transformed B-cell lines as requirement for antigen-presenting cells.Immunology. 1984 Dec;53(4):601-10. Immunology. 1984. PMID: 6209204 Free PMC article.
Cited by
-
Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome.Infect Immun. 1988 Dec;56(12):3162-6. doi: 10.1128/iai.56.12.3162-3166.1988. Infect Immun. 1988. PMID: 3182076 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous